A comprehensive view of Laboratory Corp. of America Holdings (LabCorp). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.
Labcorp introduces first commercial GFAP blood biomarker test in US that offers an efficient way to assess neurodegenerative diseases and neurological injuries; test can be conducted in hospitals, physician's offices or any of Labcorp's service centers
Published:
April 15, 2024
by Laboratory Corp. of America Holdings (LabCorp)
|
Labcorp Declares Quarterly Dividend
Published:
April 11, 2024
by Laboratory Corp. of America Holdings (LabCorp)
|
Labcorp Publishes 2023 Corporate Responsibility Report
Published:
April 10, 2024
by Laboratory Corp. of America Holdings (LabCorp)
|
FDA grants Emergency Use Authorization for Labcorp's at-home mpox testing kit to aid in detection and treatment of non-variola Orthopoxvirus, including monkeypox virus; the kit is available for physicians to order for patients aged 18 years and above
Published:
April 10, 2024
by Laboratory Corp. of America Holdings (LabCorp)
|
Labcorp expands precision oncology portfolio with launch of Labcorp Plasma Detect, a molecular residual disease platform, and enhances its Labcorp Plasma Complete circulating tumor DNA genomic profiling solution
Published:
April 08, 2024
by Laboratory Corp. of America Holdings (LabCorp)
|
Ask us about our Tissue & Hygiene market view